AURA
Price
$8.26
Change
-$0.41 (-4.73%)
Updated
Dec 18, 04:03 PM (EDT)
84 days until earnings call
VTYX
Price
$2.31
Change
-$0.06 (-2.53%)
Updated
Dec 18, 04:35 PM (EDT)
92 days until earnings call
Ad is loading...

AURA vs VTYX

Header iconAURA vs VTYX Comparison
Open Charts AURA vs VTYXBanner chart's image
Aura Biosciences
Price$8.26
Change-$0.41 (-4.73%)
Volume$100
CapitalizationN/A
Ventyx Biosciences
Price$2.31
Change-$0.06 (-2.53%)
Volume$1.4K
CapitalizationN/A
AURA vs VTYX Comparison Chart
Loading...
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AURA vs. VTYX commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AURA is a Hold and VTYX is a Hold.

COMPARISON
Comparison
Dec 18, 2024
Stock price -- (AURA: $8.67 vs. VTYX: $2.37)
Brand notoriety: AURA and VTYX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AURA: 78% vs. VTYX: 77%
Market capitalization -- AURA: $433.08M vs. VTYX: $167.58M
AURA [@Biotechnology] is valued at $433.08M. VTYX’s [@Biotechnology] market capitalization is $167.58M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AURA’s FA Score shows that 0 FA rating(s) are green whileVTYX’s FA Score has 1 green FA rating(s).

  • AURA’s FA Score: 0 green, 5 red.
  • VTYX’s FA Score: 1 green, 4 red.
According to our system of comparison, VTYX is a better buy in the long-term than AURA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AURA’s TA Score shows that 6 TA indicator(s) are bullish while VTYX’s TA Score has 4 bullish TA indicator(s).

  • AURA’s TA Score: 6 bullish, 4 bearish.
  • VTYX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, AURA is a better buy in the short-term than VTYX.

Price Growth

AURA (@Biotechnology) experienced а -2.69% price change this week, while VTYX (@Biotechnology) price change was -14.75% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.36%. For the same industry, the average monthly price growth was +0.65%, and the average quarterly price growth was +3.45%.

Reported Earning Dates

AURA is expected to report earnings on Mar 12, 2025.

VTYX is expected to report earnings on Mar 20, 2025.

Industries' Descriptions

@Biotechnology (-4.36% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AURA($433M) has a higher market cap than VTYX($168M). AURA YTD gains are higher at: -2.144 vs. VTYX (-4.049). AURA has higher annual earnings (EBITDA): -91.84M vs. VTYX (-164.94M). VTYX has more cash in the bank: 275M vs. AURA (174M). VTYX has less debt than AURA: VTYX (11M) vs AURA (19.1M). AURA (0) and VTYX (0) have equivalent revenues.
AURAVTYXAURA / VTYX
Capitalization433M168M258%
EBITDA-91.84M-164.94M56%
Gain YTD-2.144-4.04953%
P/E RatioN/AN/A-
Revenue00-
Total Cash174M275M63%
Total Debt19.1M11M174%
TECHNICAL ANALYSIS
Technical Analysis
AURAVTYX
RSI
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 20 days ago
79%
Bullish Trend 20 days ago
86%
Declines
ODDS (%)
Bearish Trend 6 days ago
82%
Bearish Trend 3 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PHPSX21.550.16
+0.75%
ProFunds Pharmaceuticals UltraSector Svc
GEQZX60.44N/A
N/A
GuideStone Funds Equity Index Investor
ABCVX23.81-0.07
-0.29%
American Beacon The London Co Inc Eq Inv
OTPSX36.21-0.16
-0.44%
ProFunds NASDAQ-100 Svc
GLESX13.44-0.08
-0.59%
GS Energy Infrastructure Fd R6 Shares

AURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AURA has been loosely correlated with VTYX. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if AURA jumps, then VTYX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AURA
1D Price
Change %
AURA100%
-2.47%
VTYX - AURA
56%
Loosely correlated
+5.33%
ABCL - AURA
53%
Loosely correlated
-2.45%
EDIT - AURA
49%
Loosely correlated
+2.70%
GBIO - AURA
48%
Loosely correlated
-6.03%
ABOS - AURA
47%
Loosely correlated
-0.51%
More

VTYX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTYX has been loosely correlated with IOVA. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if VTYX jumps, then IOVA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTYX
1D Price
Change %
VTYX100%
+5.33%
IOVA - VTYX
41%
Loosely correlated
-0.38%
AKRO - VTYX
38%
Loosely correlated
+4.72%
RAPT - VTYX
38%
Loosely correlated
-4.56%
PYPD - VTYX
37%
Loosely correlated
+2.88%
DYN - VTYX
36%
Loosely correlated
+0.23%
More